Citadel Advisors »

Atara Biotherapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.1M 261k 8.13
2024-06-30 $2.2M 261k 8.50

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Atara Biotherapeutics

Redmile Group
EcoR1 Capital
Citadel Advisors
Bank of America Corporation
Vanguard Group
Acadian Asset Management
Vestal Point Capital
Qube Research & Technologies
Tang Capital Management
Renaissance Technologies
BlackRock
BlackRock
Geode Capital Management
Centiva Capital
Staley Capital Advisers

View all funds holding Atara Biotherapeutics